Rgenix Inc raised $33,000,000 on , from Novo A/S, Sofinnova Partners.

Get alertedif Rgenix Inc gets funded!
Amount:$33,000,000
Company:
Investors:,
Industry:Biotechnology
Country:
State:
City:
United States
New York
New York City
Key people:Nancy Chang (Director)
David Darst (Director, Executive Officer)
Isabel Kurth (Director, Executive Officer)
Shahram Seyedin-noor (Director, Executive Officer)
Masoud Tavazoie (Director, Executive Officer)
Data sources:
spiderfinance.com - Rgenix Closes $33M Series B Round, Plans First Cancer Clinical Trials https://t.co/35AeYRj7i1
ift.tt - Rgenix Closes $33M Series B Round, Plans First Cancer Clinical Trials https://t.co/SZx2CLcaP4
www.finsmes.com - NYC-Based Cancer Therapeutics Company Rgenix Raises $33M in Series B Funding https://t.co/sJLropNNnt
bit.ly - NYC-Based Cancer Therapeutics Company Rgenix Raises $33M in Series B Funding https://t.co/Z4nYZvcv8t https://t.co/9aXYh1T3jl
www.bio-itworld.com - Rgenix Closes $33 Million Series B Round https://t.co/FO8pArh4YS via @bioitworld
www.bioportfolio.com - #GSK News: Cancer play Rgenix raises $33M - Rgenix Inc. New York N.Y. raised $33 million in a series B round le... https://t.co/C6ybfj4K34
www.biopharmadive.com - NYC-based Rgenix raises $33 million to advance cancer immunotherapy | BioPharma Dive https://t.co/tGyi3AVDEW
www.pharmamedtechbi.com - Rgenix raises $33mm through Series B round: Rgenix Inc. (cancer immunotherapies) raised $33mm through its Ser... https://t.co/nMfMkC1afE
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!